World Radiofrequency Ablation Devices Market was valued at $1,729.7 million in 2015 and shall grow at a CAGR of 11.8% to reach $3,785.3 million by 2022

Big Market Research adds a new report “Radiofrequency Ablation Devices Market -Size, Share, Trends, Forecast 2022”

Radiofrequency ablation (RFA) is a medical process in which a dysfunctional tissue is ablated using the heat generated by high-frequency electromagnetic waves. Advantages of using radiofrequency current for ablation are that there is no need for general anesthetics as the nerves or muscles are not directly stimulated and the treatment is very specific to the desired tissue, without causing any significant collateral damage. It is a minimally invasive procedure that is utilized in various fields of medicine such as pain management, cardiac rhythm management, oncology, and renal denervation for hypertension. RFA helps to shrink and destroy the tumor cells. In pain management, it is used to reduce pain by heat destruction of nerves that conduct nerve impulses.

Get Sample Copy of report @ https://goo.gl/ck5vxj

The world radiofrequency ablation devices market was valued at $1,729.7 million in 2015 and shall grow at a CAGR of 11.8% to reach $3,785.3 million by 2022. This is attributed to the increase in demand for minimally invasive surgeries, rise in prevalence of cancer, high efficacy, and short duration of the procedure. The rise in the incidence of patients with chronic pain due to the increase in prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis also contributed towards the growth of the RFAD market. However, the cost associated with this technology and lack of awareness among patients hinders the market growth.

The world RFAD market is segmented into three categories: application, product type, and geography. Based on the type of application, the market is bifurcated into oncology, pain management and cardiology. Based on product type, it is divided into devices, and disposables. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Check discount on this report @ https://goo.gl/ABqAS3

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the RFAD market. On August 3, 2016, Boston Scientific Corporation completed the acquisition of Cosman Medical, which helped it to improve its product portfolio of non-opioid solutions for chronic pain. On August 7, 2016, St. Jude Medical, Inc. acquired NeuroTherm, Inc., which is expected to accelerate the growth of St. Jude Medical’s business in chronic pain and strengthen its position as a global leader in developing therapies for chronic pain treatment.

KEY MARKET BENEFITS:

• The world radiofrequency ablation devices market report provides an extensive analysis of the current market trends and future estimations through 2014–2022.
• The market scenario is comprehensively analyzed with respect to the application and product type.
• Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS:

The world radiofrequency ablation devices market segmentation is illustrated as follows:

By Application

Cardiology
• Conventional RF Ablation Catheters
• Irrigated Tip RF Ablation Catheters
Oncology
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Liver Cancer
• Kidney Cancer
• Spinal Metastases
• Other Cancers
Pain management
• Neck Pain
• Shoulder Pain
• Upper Back Pain
• Lower Back Pain
• Knee Pain
• Other Pain Syndromes

By Product Type

• Devices
• Disposables

By Geography

North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Russia
• Rest of Europe
Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Taiwan
• Rest of Asia-Pacific
LAMEA
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Republic of South Africa
• Rest of LAMEA

COMPANY PROFILES:

The key players profiled in this report are listed below:
• Halyard Health, Inc.
• Stryker Corporation
• St. Jude Medical, Inc.
• Medtronic Plc
• Boston Scientific Corporation
• C. R. Bard, Inc.
• AngioDynamics, Inc.
• Hologic, Inc.
• AtriCure, Inc.
• Johnson & Johnson

Other players in the RFAD market include (profiles not included in the report)

• Baylis Medical
• Arthrex, Inc.
• inomed Medizintechnik GmbH
• Sutter Medizintechnik GmbH
• Bramsys Indústria e Comércio Ltda
• ENDO-FLEX GmbH
• Epimed International
• sfm medical devices GmbH

View Complete Report @ http://www.bigmarketresearch.com/radiofrequency-ablation-devices-market

About Us
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Our research services ranges into different domains and penetrates in different verticals so that we can carter to diverse needs of various organization. Not wrong to quote that this is the hotspot for research needs of yours.

Contact us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: + 1-503-894-6022
Toll Free: + 1-800-910-6452
Fax: +1 (855) 550–5975
Email: help@bigmarketresearch.com
Web: http://www.bigmarketresearch.com
Blog: http://www.bigmarketresearch.blogspot.com

This release was published on openPR.